Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in

MEPS Statistical Brief No.514: Reported Diagnosis & Prescription Utilization Related To Attention Deficit Hyperactivity Disorder In Children Ages 5-17, 2008-2015

The study was released in August 2018 by the Agency for Healthcare Research and Quality (AHRQ). The researcher analyzed data from the Medical Expenditure Panel Survey Household Component (MEPS-HC) for 2008 and 2015 for children ages 5 to 17 diagnosed with attention deficit/hyperactivity disorder (ADHD). The goal was to determine diagnosis trends for younger (ages 5 to 12) and older children (ages 13 to 17), and trends in pharmaceutical treatment for ADHD . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.